
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0132 | -4.90706319703 | 0.269 | 0.2799 | 0.241 | 134106 | 0.26206974 | CS |
4 | -0.0062 | -2.36641221374 | 0.262 | 0.475 | 0.24 | 5554299 | 0.35596604 | CS |
12 | -0.2832 | -52.5417439703 | 0.539 | 0.6196 | 0.24 | 2286279 | 0.36280422 | CS |
26 | -0.3042 | -54.3214285714 | 0.56 | 1.09 | 0.24 | 1146901 | 0.39393296 | CS |
52 | -1.1042 | -81.1911764706 | 1.36 | 1.87 | 0.24 | 627937 | 0.4450659 | CS |
156 | -3.2642 | -92.7329545455 | 3.52 | 4.2 | 0.24 | 221548 | 0.57050262 | CS |
260 | -14.7042 | -98.2901069519 | 14.96 | 19.56 | 0.24 | 439578 | 7.83381728 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions